Supply Chain Council of European Union |
Supply Chain Risk

CPhI keynote tackles top trends for the CDMO sector

Gil Roth (GR), president of the Pharma and Biopharma Outsourcing Association (PBOA), is slated to deliver a keynote titled the Future of Drug Manufacturing on October 6, from 11 am to 12 noon during CPhI Festival of Pharma. Roth spoke to Outsourcing-Pharma (OSP) about trends impacting the contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO) sector, and what shifts might lie ahead.

OSP: Could you please tell us about PBOA in a nutshell—who you are, who your members are, services/products you provide, etc.

GR: PBOA is a nonprofit trade association that advocates for the regulatory, legislative, and general business interests of the CMO/CDMO sector. We have approximately three dozen member companies, covering the span of service offerings, technologies, and scale: small and large molecule therapeutics and vaccines, single facility to global multinational, pure-play to embedded models, and more; we bring those companies together to give the sector a collective voice with FDA and other regulatory bodies, and to help lobby on their behalf with the US Congress.

Having a trade association also enables these companies to talk to one another, to exchange ideas in our working groups and committees, and learn about best practices from their peers. Initiatives within our working groups have led to meetings with FDA and Health Canada, in which our members have been able to interact directly with regulators to discuss key areas of interest.

In addition, we have more than a dozen affiliate members, which are companies that provide goods or services to our full members. These include marketing companies, equipment and software providers, training companies, and trade shows.

Related posts

Don’t neglect HIV patients in Covid fight: The Standard


Watchdog threat over Helensburgh waterfront project


Financial astrology for the successful investor & trade


Leave a Comment